IN8BIO INC INAB
COM · Common Stock · CUSIP 45674E109
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersNew York, NY
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.31.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 14 |
| Q4 2021 | 16 |
| Q1 2022 | 16 |
| Q2 2022 | 17 |
| Q3 2022 | 19 |
| Q4 2022 | 17 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 10 | 4 |
| Q1 2022 | 10 | 3 |
| Q2 2022 | 6 | 6 |
| Q3 2022 | 12 | 9 |
| Q4 2022 | 8 | 9 |
Biggest buyers
| NORTHERN TRUST CORP | New | +13.3k |
| DIMENSIONAL FUND ADVISORS LP | New | +11.2k |
| WELLS FARGO & COMPANY/MN | Added | +10.1k |
| BlackRock Inc. | Added | +8.2k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +6.3k |
| Tower Research Capital LLC (TRC) | Added | +4.9k |
| Sigma Planning Corp | Added | +400 |
| BANK OF AMERICA CORP /DE/ | New | +20 |
Biggest sellers
| Precept Management LLC | Sold out | -50.0k |
| Voss Capital, LP | Reduced | -37.6k |
| Warberg Asset Management LLC | Sold out | -15.0k |
| United Asset Strategies, Inc. | Sold out | -14.0k |
| UBS Group AG | Reduced | -5.3k |
| HighTower Advisors, LLC | Reduced | -4.2k |
| MORGAN STANLEY | Sold out | -1.5k |
| VANGUARD GROUP INC | Reduced | -872 |
| ROYAL BANK OF CANADA | Sold out | -140 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Ho William Tai-Wei 13G · exempt (held before listing) filed 2025-02-14 | 5.6% |
Fell to 5% or below in the last year: BIOS Fund II, LP (4.0%, 2025-12-29)
Insider purchases and sales in Q4 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 1 | $1.0m | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 12 | $5.4m | 0 | — | — |
| Q4 2022 | 2 | $186.0k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-12-12 | BIOS Fund II, LP +9 Director · See footnote | Bought | $186.0k75.0k shares |
| 2022-12-12 | Cavu Management, LP +4 Director · See footnote | Bought | $186.0k75.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Voss Capital, LP 0.15% of their portfolio | 338.0k $780.8k | Reduced -37.6k |
| Stonegate Investment Group, LLC 0.02% of their portfolio | 232.3k $536.6k | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 168.7k $389.6k | Reduced -872 |
| Sigma Planning Corp 0.01% of their portfolio | 99.2k $229.0k | Added +400 |
| Rock Creek Group LLC 0.02% of their portfolio | 81.6k $188.4k | Unchanged |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 74.0k $170.9k | Unchanged |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 70.0k $161.8k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 58.7k $135.0k | Added +6.3k |
| BlackRock Inc. 0.00% of their portfolio | 31.5k $72.8k | Added +8.2k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 13.3k $30.6k | New |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 11.2k $26.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 10.1k $23.4k | Added +10.1k |
| HighTower Advisors, LLC 0.00% of their portfolio | 10.0k $23.0k | Reduced -4.2k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 6.7k $15.0k | Added +4.9k |
| UBS Group AG 0.00% of their portfolio | 3.5k $8.0k | Reduced -5.3k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 20 $46 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |